Article
The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine…
Therapeutics and Clinical Risk Management · 2018 · Bala C, Rusu A, Ciobanu DM, Craciun AE, Roman G
Key facts
| Title | The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus |
|---|---|
| First author | Bala C, Rusu A, Ciobanu DM, Craciun AE, Roman G |
| Journal | Therapeutics and Clinical Risk Management |
| Published | May 28, 2018 |
| DOI | 10.2147/TCRM.S162086 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1